A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS)
Titel:
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS)
Auteur:
Sallman, David A. Komrokji, Rami S. Sweet, Kendra L. Mo, Qianxing McGraw, Kathy L. Duong, Vu H. Zhang, Ling Nardelli, Lisa Ann Padron, Eric List, Alan F. Lancet, Jeffrey E.